Mandy Kader Kondé

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ PDF Chat Comprehensive characterization of cellular immune responses following Ebola virus infection 2016 Christine Dahlke
Sebastian Lunemann
Rahel Kasonta
Benno Kreuels
Stefan Schmiedel
My Linh Ly
Sarah K. Fehling
Thomas Strecker
Stephan Becker
Marcus Altfeld
2
+ PDF Chat A Recombinant Vesicular Stomatitis Virus Ebola Vaccine 2015 Jason A. Regules
John H. Beigel
Kristopher Paolino
Jocelyn Voell
Amy R. Castellano
Zonghui Hu
P. Rubio Muñoz
James E. Moon
Richard C. Ruck
Jason W. Bennett
2
+ PDF Chat Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial 2015 Ana María Henao-Restrepo
Ira M. Longini
Matthias Egger
Natalie E. Dean
W. John Edmunds
Anton Camacho
Miles W. Carroll
Moussa Doumbia
Bertrand Draguez
Sophie Duraffour
1
+ Design and Analysis of Cluster Randomization Trials in Health Research 2001 William W. Davis
1
+ A Multiple Testing Procedure for Clinical Trials 1979 Peter C. O’Brien
Thomas R. Fleming
1
+ Subverting Randomization in Controlled Trials 1995 Kenneth F. Schulz
1
+ PDF Chat Interval Estimation for a Binomial Proportion 2001 Lawrence D. Brown
Tommaso Cai
Anirban Dasgupta
1
+ Design and Analysis of Vaccine Studies 2009 M. Elizabeth Halloran
Ira M. Longini
Claúdio J. Struchiner
1
+ PDF Chat Unique human immune signature of Ebola virus disease in Guinea 2016 Paula Ruibal
Lisa Oestereich
Anja Lüdtke
Beate Becker‐Ziaja
David M. Wozniak
Romy Kerber
Miša Korva
Mar Cabeza-Cabrerizo
Joseph Akoi Boré
Fara Raymond Koundouno
1
+ PDF Chat Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults 2017 Scott A. Halperin
José Ramón Arribas
Richard Rupp
Charles P. Andrews
Laurence Chu
Rituparna Das
Jakub K. Simon
Matthew T. Onorato
Kenneth Liu
Jason Martin
1
+ PDF Chat Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study 2017 D. Gray Heppner
Tracy Kemp
Brian K. Martin
W. Jay Ramsey
Richard Nichols
Emily J. Dasen
Charles J. Link
Rituparna Das
Zhi Jin Xu
Eric Sheldon
1
+ PDF Chat Analysis of CD8 <sup>+</sup> T cell response during the 2013–2016 Ebola epidemic in West Africa 2018 Saori Sakabe
Brian M. Sullivan
Jessica N. Hartnett
Refugio Robles‐Sikisaka
Karthik Gangavarapu
Beatrice Cubitt
Brian C. Ware
Dylan Kotliar
Luis M. Branco
Augustine Goba
1
+ PDF Chat Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study 2019 Mamadou Saliou Kalifa Diallo
Muriel Rabilloud
Ahidjo Ayouba
Abdoulaye Touré
Guillaume Thaurignac
Alpha Kabinet Keïta
Christelle Butel
Cécé Kpamou
Thierno Alimou Barry
Mariama Djouldé Sall
1
+ PDF Chat Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection 2019 Andrea Menicucci
Allen Jankeel
Heinz Feldmann
Andrea Marzi
Ilhem Messaoudi
1
+ PDF Chat Effect of Gamma Irradiation on the Antibody Response Measured in Human Serum from Subjects Vaccinated with Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine 2019 Rebecca J. Grant-Klein
Joseph M. Antonello
Richard Nichols
Sheri Dubey
Jakub K. Simon
1
+ PDF Chat Ebola Virus Disease among Children in West Africa 2015 1
+ PDF Chat Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections 2014 1
+ Cluster Randomised Trials 2009 Eva Batistatou
1
+ Survival and Event History Analysis: A Process Point of View 2008 Odd O. Aalen
Oernulf Borgan
Håkon K. Gjessing
1
+ Design and Analysis of Cluster Randomization Trials in Health Research 2000 Allan Donner
Neil Klar
1